Best Peptide Protocols
    Metabolic / Weight LossSingle

    Cagrilintide 5mg: Dosage, Reconstitution & Research Protocol Guide

    Dosing ranges, reconstitution steps, administration details, cycle length, and storage guidance for Cagrilintide (5 mg Vial).

    Strength & Form:5 mg Vial10 mg Vial
    Cagrilintide (5 mg Vial) peptide vial

    Cagrilintide (5 mg Vial)

    5 mg Research Peptide

    Shop on ResearchLabs

    Quick Facts

    Type
    Single
    Category
    Metabolic / Weight Loss
    Vial Strength
    5 mg
    Status
    Research

    Research Purposes Only

    This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.

    Download Guide

    Save the complete Cagrilintide 5mg research guide as a PDF.

    Educational and research use only. Not medical advice.

    Reference

    Sources used for this guide are listed in our research database .

    What Is Cagrilintide 5mg?

    Cagrilintide 5mg Vial Overview

    Cagrilintide is a long-acting acylated amylin analog that mimics the satiety-signaling effects of amylin, co-secreted with insulin from pancreatic beta cells. It reduces food intake, slows gastric emptying, and promotes fullness. Clinical data shows significant weight reduction as monotherapy and even greater effects when combined with GLP-1 receptor agonists like semaglutide.

    Cagrilintide 5mg Quick Reference

    Cagrilintide 5mg Vial Specifications

    Peptide
    Cagrilintide (5 mg Vial) (NNMT inhibitor)
    Vial Content
    5 mg total peptide
    Category
    Metabolic / Weight Loss
    Administration Method
    Subcutaneous injection
    Common Use Case
    Weight management and appetite regulation research

    Cagrilintide 5mg Compared With Other Formats

    Details that distinguish this 5 mg format include:

    • Long-acting amylin analog
    • Synergistic with GLP-1 agonists
    • Once-weekly dosing potential

    How Does Cagrilintide Work?

    Cagrilintide Mechanism of Action

    Cagrilintide is a long-acting acylated amylin analog that mimics the satiety-signaling effects of amylin. It reduces food intake, slows gastric emptying, and promotes fullness through central appetite regulation pathways.

    What Are the Potential Benefits of Cagrilintide?

    Cagrilintide Research Findings and Observed Outcomes

    Findings and reported areas of study for Cagrilintide (5 mg Vial) include:

    • Reduced food intake
    • Slowed gastric emptying
    • Enhanced satiety signaling
    • Synergy with GLP-1 agonists

    These observations are discussed for research and educational reference only and are not medical claims.

    What Do You Need to Reconstitute Cagrilintide 5mg?

    Cagrilintide 5mg Supplies for Reconstitution and Handling

    • •Insulin syringes (29–31g)
    • •Bacteriostatic water
    • •Alcohol prep pads
    • •Sharps container

    Supplies listed are for laboratory handling and research preparation purposes only.

    Cagrilintide 5mg Administration and Research Protocol

    Cagrilintide Injection Route, Frequency and Timing

    RouteSubcutaneous injection
    FrequencyOnce weekly
    TimingSame day each week

    Cagrilintide 5mg Dosage Guide

    Cagrilintide Dosage Ranges

    The ranges below pair the listed dose with the draw volume for this product strength.

    Low Range0.25 mg/week
    Standard Range1 mg/week
    Upper Range1.25 mg/week (50 units max)

    Cagrilintide 5mg Dosage to Syringe Units

    Based on reconstitution below

    Target Daily DoseDraw VolumeUnits
    0.25 mg0.10 mL10 units
    1 mg0.40 mL40 units
    1.25 mg0.50 mL50 units

    This dosing table is unique to the 5 mg vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

    How Long Does a Cagrilintide 5mg Vial Last?

    Cagrilintide 5mg Duration by Research Dose

    At common research doses, one 5 mg vial of Cagrilintide typically supports:

    0.25 mg/week~20 weeks
    1 mg/week~5 weeks
    1.25 mg/week (50 units max)~2.5 weeks

    How to Reconstitute Cagrilintide 5mg

    Cagrilintide 5mg Reconstitution With Bacteriostatic Water

    This section applies specifically to the Cagrilintide (5 mg Vial).

    Recommended Diluent
    Bacteriostatic water
    Diluent Volume
    2 mL
    Final Concentration
    2.5 mg/mL

    Cagrilintide 5mg Mixing Instructions

    1. 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
    2. 2Wash hands thoroughly and prepare a clean workspace with all supplies.
    3. 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
    4. 4Clean the rubber stopper of the vial with an alcohol prep pad.
    5. 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
    6. 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
    7. 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.

    Cagrilintide Stacks and Research Combinations

    Cagrilintide and Compatible Research Pairings

    In research settings, Cagrilintide (5 mg Vial) is sometimes paired with peptides such as:

    • Semaglutide: CagriSema combination for enhanced weight loss

    Factors That May Affect Cagrilintide Research Outcomes

    Supporting Factors for Cagrilintide Research

    Factors recorded alongside this protocol include:

    • Calorie-conscious diet
    • Regular exercise
    • Adequate hydration
    • Sleep optimization

    These factors can affect how research observations are interpreted.

    Cagrilintide Side Effects and Safety Considerations

    Cagrilintide 5mg Tolerability Notes

    Generally well-tolerated.

    Some individuals report:

    • Nausea (dose-dependent)
    • Injection site reactions
    • Decreased appetite

    How to Store Cagrilintide Before and After Reconstitution

    Cagrilintide 5mg Storage Requirements

    Unreconstituted
    Refrigerate
    Reconstituted
    Refrigerate at 2–8°C
    Post-Mix Stability
    Up to 4 weeks

    Who Should Avoid Cagrilintide?

    This peptide is generally not recommended for:

    • Pregnant/breastfeeding
    • History of medullary thyroid carcinoma
    • Pancreatitis history

    Cagrilintide 5mg FAQs

    What is CagriSema?

    CagriSema is the combination of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist). Clinical trials show this combination produces greater weight loss than either agent alone.

    Where to Buy Cagrilintide 5mg for Research

    Cagrilintide 5mg Purchasing and Research Supply Notes

    Before ordering Cagrilintide (5 mg Vial), review the product label, available testing documents, and storage instructions.

    Check the ResearchLabs listing for:

    • Available testing documents
    • Product strength and concentration
    • Storage and handling instructions
    • Current product availability

    View the current listing for Cagrilintide (5 mg Vial):

    → View on ResearchLabs

    Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.

    Related Metabolic / Weight Loss Peptides

    Adipotide (FTPP) (10 mg Vial) productAdipotide (FTPP) (10 mg Vial)AOD-9604 (5 mg Vial) productAOD-9604 (5 mg Vial)5-Amino-1MQ (5 mg Vial) product5-Amino-1MQ (5 mg Vial)Cagrilintide (10 mg Vial) productCagrilintide (10 mg Vial)Mazdutide (10 mg Vial) productMazdutide (10 mg Vial)Retatrutide (10 mg Vial) productRetatrutide (10 mg Vial)